Table: Hisamitsu -9-MTH group results
Jan 8 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Nov 30, 2015 Nov 30, 2014 Feb 29, 2016
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 122.28 114.94 164.30
(+6.4 pct) (-0.2 pct) (+4.8 pct)
Operating 23.32 15.64 27.40
(+49.2 pct) (-15.4 pct) (+33.5 pct)
Recurring 23.47 22.64 28.50
(+3.7 pct) (-11.3 pct) (+0.0 pct)
Net 15.32 14.48 18.30
(+5.8 pct) (-24.6 pct) (-2.6 pct)
EPS 179.51 yen 168.98 yen 213.62 yen
EPS Diluted 179.49 yen
Ann Div 80.00 yen 80.00 yen
-Q2 div 40.00 yen 37.50 yen
-Q4 div 42.50 yen 40.00 yen
NOTE - Hisamitsu Pharmaceutical Co Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO